FLI1 and nasopharyngeal carcinoma: In this study, the authors delineate a FLI1-mediated Kyn metabolic mechanism as an immune evasion mechanism in NPC and they show that pharmacological inhibition of FLI1 improves both spontaneous and checkpoint therapy-induced immune responses.